INS and coronary artery disorder: Although the potential clinical uses of AIP as a blood lipid indicator associated with coronary artery disease, blood pressure, diabetes and vascular events have been recently reported in several other studies [107,113,114,115,116,117,118,119,120], to the best of our knowledge this is the first study examining its extensive association with range of CM biomarkers within this target population to establish its association with insulin.